Global Biosurgery Market is Predicted to Value Over USD 19.5 Billion by 2026 End

  • 26 Sep 2019

Global Biosurgery Market is predicted to arrive at a value of USD 19.5 billion by the year end of 2026, along with a CAGR of over 6% during the forecast period 2019 to 2026


Biosurgery has allowed for new avenues namely regenerative healing, surgical care and tissue and wound management. The different products that have been introduced under the biosurgery category have gained significant momentum in several different areas in the medical field such as gynecology, orthopedic, neurosurgery, spine-related and cardiovascular treatments. Biosurgery has experienced revolutionary ideas in regenerative healing by integrating synthetics and biologics. Players in the healthcare sector have taken to using and developing advanced biomaterials which has pushed for much growth in the market. Among the most widely used biosurgery products includes soft tissue attachments, adhesion barriers, biological mesh, collagen and fibrin sealant, hemostats, and bone morphogenetic proteins. The investments made by the government sector has shown to have a positive effect on healthcare infrastructure which drives the global biosurgery market growth.


Biosurgery market has been estimated to gain advantage from opportunities arising out of the sheer volume of surgeries, on a global scale. Many surgeries are often attributed to activities related to sports as well as injuries occurring from trauma. The market is also expected to experience benefits from the ageing population which is prevalent in many emerging nations. The growing need for novel biomaterials in the avenues of tissue management and intra-operative has cultivated a global biosurgery market trend. Life science firms curating products for surgical care are turning their attention towards new opportunities in biosurgery with getting involved in several activities related to research and development. Innovative inventions in synthetic biology for the regeneration of tissues have also been instrumental in enhancing market prospects. Companies are putting on efforts in developed nations to develop improved and effective biologics are also propelling the consistent market growth.


Based on the study, we observe how there have been many market spaces who possess untapped potential. In fact, the arrival of new and innovative products, particularly that of reconstructive surgery, have been instrumental in new revenue structures in developing economies, namely in the Asia Pacific. In addition, the need for new surgical practices in these regions is projected to allow for more future prospects. Relaxation of rules and regulations by governing bodies make it much easier for developed countries to gain opportunities. However, a dearth of clinical professionals in underdeveloped regions might impede the consistent expansion of the global biosurgery market size. 


Key players considered in the analysis of the market are Baxter International (US), C.R. Bard (US), Medtronic (Ireland), MAQUET Holding (Germany), CryoLife (US), Stryker Corporation (US), Integra Lifesciences (US), Pfizer (US), and CSL Limited (Australia)Johnson & Johnson (US), Sanofi (France), Cohera Medical (US), Hemostasis (US), B. Braun (Germany). 


Global Biosurgery Market Segmentation:

By Product Type:

• Bone-Graft Substitutes

o Demineralized Bone Matrix

o Synthetic Bone Grafts

o Bone Morphogenetic Proteins

o Other Bone-Graft Substitutes

• Soft-Tissue Attachments 

o Synthetic Meshes

o Biological Meshes

o Allografts

o Xenografts

• Hemostatic Agents 

o Thrombin-Based Hemostatic Agents

o Oxidized Regenerated Cellulose-Based Hemostatic Agents

o Combination Hemostatic Agents

• Surgical Sealants and Adhesives 

• Natural/Biological Sealants and Adhesives

o By Type

  1. Fibrin Sealants
  2. Collagen-Based Sealants
  3. Gelatin-Based Sealants
  4. Albumin-Based Sealants
  5. Other Natural/Biological Sealants

o By Origin

  1. Human Blood-Based Sealants and Adhesives
  2. Animal-Based Sealants and Adhesives
  3. Synthetic and Semi-Synthetic Sealants and Adhesives
  4. Peg Hydrogels
  5. Cyanoacrylate-Based Sealants and Adhesives
  6. Urethane-Based Sealants and Adhesives
  7. Other Synthetic and Semi-Synthetic Sealants and Adhesives

• Adhesion Barriers 

o Synthetic Adhesion Barriers

o Hyaluronic Acid-Based Adhesion Barriers

o Regenerated Cellulose-Based Adhesion Barriers

o Peg-Based Adhesion Barriers

o Thermal Synthetic Adhesion Barriers

o Natural Adhesion Barriers

o Collagen & Protein Adhesion Barriers

o Fibrin-Based Adhesion Barriers

o Staple-Line Reinforcement Agents 


By Application:  

• Orthopedic Surgery

• General Surgery

• Neurological Surgery

• Cardiovascular Surgery

• Reconstructive Surgery

• Gynecological Surgery

• Urological Surgery

• Thoracic Surgery 


By Region: 

• North America

• Europe

• Asia Pacific

• Latin America

• The Middle East and Africa


FutureWise Key Takeaways: 

• Growth prospects

• SWOT analysis

• Key trends

• Key data-points affecting market growth


Objectives of the Study:

• To provide with an exhaustive analysis on the global bio surgery market by product type, by application and by region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• To evaluate and forecast micro-markets and the overall market

• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and the Middle East & Africa

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions



Get unlimited analyst support and customise this study further to your requirements, contact